ARHGAP45 and leukemia: The capability of HMHA-1 specific immunotherapy to eradicate leukemia or solid tumors strongly depends on whether HMHA-1 is expressed on the earliest progenitor/stem cell from which the targeted leukemia or solid tumor can repopulate.